Quantcast

RoosterBio plans new products from partnership with Canadian firm

RoosterBio Inc., a stem cell tools and technology company in Frederick, announced a strategic collaboration with a Canadian firm with the aim of speeding up development of the regenerative medicine field. Under the collaboration, the Maryland company gains an exclusive, worldwide license to Tissue Regeneration Therapeutics Inc.'s patents related to the making and sale of human umbilical-cord-derived mesenchymal ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *

*